chr18-62106804-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_176787.5(PIGN):​c.1752G>A​(p.Leu584Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 1,603,330 control chromosomes in the GnomAD database, including 42,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2934 hom., cov: 32)
Exomes 𝑓: 0.22 ( 39818 hom. )

Consequence

PIGN
NM_176787.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.250

Publications

19 publications found
Variant links:
Genes affected
PIGN (HGNC:8967): (phosphatidylinositol glycan anchor biosynthesis class N) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This protein is expressed in the endoplasmic reticulum and transfers phosphoethanolamine (EtNP) to the first mannose of the GPI anchor. Two alternatively spliced variants, which encode an identical isoform, have been reported. [provided by RefSeq, Jul 2008]
PIGN Gene-Disease associations (from GenCC):
  • multiple congenital anomalies-hypotonia-seizures syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
  • Fryns syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 18-62106804-C-T is Benign according to our data. Variant chr18-62106804-C-T is described in ClinVar as Benign. ClinVar VariationId is 403302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGNNM_176787.5 linkc.1752G>A p.Leu584Leu synonymous_variant Exon 19 of 31 ENST00000640252.2 NP_789744.1 O95427A0A024R2C3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGNENST00000640252.2 linkc.1752G>A p.Leu584Leu synonymous_variant Exon 19 of 31 1 NM_176787.5 ENSP00000492233.1 O95427
PIGNENST00000400334.7 linkc.1752G>A p.Leu584Leu synonymous_variant Exon 18 of 30 1 ENSP00000383188.2 O95427
PIGNENST00000638424.1 linkn.1752G>A non_coding_transcript_exon_variant Exon 17 of 29 5 ENSP00000491963.1 A0A1W2PQZ1

Frequencies

GnomAD3 genomes
AF:
0.169
AC:
25729
AN:
152074
Hom.:
2933
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0444
Gnomad AMI
AF:
0.249
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.00501
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.280
Gnomad NFE
AF:
0.248
Gnomad OTH
AF:
0.192
GnomAD2 exomes
AF:
0.173
AC:
40731
AN:
234998
AF XY:
0.176
show subpopulations
Gnomad AFR exome
AF:
0.0397
Gnomad AMR exome
AF:
0.106
Gnomad ASJ exome
AF:
0.253
Gnomad EAS exome
AF:
0.00283
Gnomad FIN exome
AF:
0.237
Gnomad NFE exome
AF:
0.237
Gnomad OTH exome
AF:
0.205
GnomAD4 exome
AF:
0.225
AC:
326239
AN:
1451138
Hom.:
39818
Cov.:
31
AF XY:
0.223
AC XY:
160565
AN XY:
720926
show subpopulations
African (AFR)
AF:
0.0379
AC:
1261
AN:
33310
American (AMR)
AF:
0.113
AC:
4928
AN:
43804
Ashkenazi Jewish (ASJ)
AF:
0.248
AC:
6442
AN:
25924
East Asian (EAS)
AF:
0.00140
AC:
55
AN:
39378
South Asian (SAS)
AF:
0.114
AC:
9616
AN:
84428
European-Finnish (FIN)
AF:
0.235
AC:
12423
AN:
52814
Middle Eastern (MID)
AF:
0.242
AC:
1392
AN:
5746
European-Non Finnish (NFE)
AF:
0.251
AC:
277631
AN:
1105710
Other (OTH)
AF:
0.208
AC:
12491
AN:
60024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
11573
23147
34720
46294
57867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9176
18352
27528
36704
45880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.169
AC:
25734
AN:
152192
Hom.:
2934
Cov.:
32
AF XY:
0.167
AC XY:
12390
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0443
AC:
1840
AN:
41554
American (AMR)
AF:
0.152
AC:
2319
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
869
AN:
3472
East Asian (EAS)
AF:
0.00521
AC:
27
AN:
5182
South Asian (SAS)
AF:
0.108
AC:
520
AN:
4822
European-Finnish (FIN)
AF:
0.246
AC:
2597
AN:
10574
Middle Eastern (MID)
AF:
0.277
AC:
81
AN:
292
European-Non Finnish (NFE)
AF:
0.248
AC:
16846
AN:
67982
Other (OTH)
AF:
0.194
AC:
410
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1027
2055
3082
4110
5137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.222
Hom.:
6663
Bravo
AF:
0.157
Asia WGS
AF:
0.0810
AC:
283
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Inborn genetic diseases Benign:1
Mar 19, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
3.2
DANN
Benign
0.59
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9319997; hg19: chr18-59774037; COSMIC: COSV62952142; COSMIC: COSV62952142; API